Biotech Startup Rubius to Double Footprint With New Kendall Square Lease
The fast-growing company will anchor 399 Binney St., an Alexandria Real Estate Equities property. Source: BioSpace
The fast-growing company will anchor 399 Binney St., an Alexandria Real Estate Equities property. Source: BioSpace
A look at a few bargains in today's choppy market. Source: BioSpace
The biggest challenge for the FDA’s 10-year-old Sentinel program for post-market safety monitoring of medical products is having to deal with a wide range of partners and data sources, according…
The Council of Economic Advisers issued new recommendations for reducing drug pricing, including changes in government policies and regulations, such as moving Medicare Part B drug coverage into Part D.…
The budget deal approved by lawmakers in the early hours on Friday raised caps on non-defense discretionary spending by $63 billion in fiscal 2018 and $68 billion in fiscal 2019,…
The FDA issued Wuhan Chinese Moxibustion Technology a warning letter for manufacturing adulterated products, and for quality and sanitation deficiencies. Source: Drug Industry Daily
A bipartisan group of members of the Senate Health Committee introduced a bill to increase National Institutes of Health research into non-opioid pain treatments. Source: Drug Industry Daily
Elastagen's revolutionary technology is based on recombinant human tropoelastin, the precursor of elastin which is a key component of youthful skin. Source: BioSpace
This biotech could potentially could be a better value. Source: BioSpace
Another potential treatment for Alzheimer's disease has been tossed into the rubbish bin. Source: BioSpace